Multi-drug resistant tuberculosis in women

dc.contributor.authorStoltz, Anton Carel
dc.contributor.emailanton.stoltz@up.ac.zaen_ZA
dc.date.accessioned2015-07-04T09:59:25Z
dc.date.available2015-07-04T09:59:25Z
dc.date.issued2015
dc.description.abstractThe World Health Organisation (WHO) estimates a staggering 8.6 million new tuberculosis cases every year (Global TB report, 2013).1 Seventy five percent of the 8.6 million cases are from the Africa region. More than 500 000 of these cases are new multi-drug resistant tuberculosis (MDR TB) that has doubled from 2009 as well as 2011 and this number is currently doubling annually. Many of these cases are primary MDR TB infection or re-infection rather than previously treated tuberculosis progressing to MRD TB.2 Evidence is growing for increased transmission in congregate settings and hospitals. Currently drug susceptible tuberculosis treatment rapidly induces negative transmission compared to multi- and extreme drug resistant tuberculosis treatment that is not effective and the patient can be positive for months and still transmitting disease.en_ZA
dc.description.librarianam2015en_ZA
dc.description.urihttp://reference.sabinet.co.za/sa_epublication/medogen_ZA
dc.identifier.citationStoltz, AC 2015, 'Multi-drug resistant tuberculosis in women', Obstetrics and Gynaecology Forum, vol. 25, no. 2, pp. 13-16.en_ZA
dc.identifier.issn1027-9148
dc.identifier.urihttp://hdl.handle.net/2263/46302
dc.language.isoenen_ZA
dc.publisherIn House Publicationsen_ZA
dc.rightsIn House Publicationsen_ZA
dc.subjectWomenen_ZA
dc.subjectAfricaen_ZA
dc.subjectTuberculosis (TB)en_ZA
dc.subjectMultidrug-resistant tuberculosis (MDR-TB)en_ZA
dc.titleMulti-drug resistant tuberculosis in womenen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Stoltz_Multidrug_2015.pdf
Size:
626.18 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: